EP1094012B1 - Fermeture en plastique pour flacons et autres recipients medicaux - Google Patents

Fermeture en plastique pour flacons et autres recipients medicaux Download PDF

Info

Publication number
EP1094012B1
EP1094012B1 EP00121655A EP00121655A EP1094012B1 EP 1094012 B1 EP1094012 B1 EP 1094012B1 EP 00121655 A EP00121655 A EP 00121655A EP 00121655 A EP00121655 A EP 00121655A EP 1094012 B1 EP1094012 B1 EP 1094012B1
Authority
EP
European Patent Office
Prior art keywords
closure
container
plastic closure
polymer
plastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP00121655A
Other languages
German (de)
English (en)
Other versions
EP1094012A2 (fr
EP1094012A3 (fr
Inventor
Hubert Jansen
Jean-Claude Thibault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of EP1094012A2 publication Critical patent/EP1094012A2/fr
Publication of EP1094012A3 publication Critical patent/EP1094012A3/fr
Application granted granted Critical
Publication of EP1094012B1 publication Critical patent/EP1094012B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means

Definitions

  • This invention relates to an improved plastic closure such as a cap or collar for closing or sealing containers such as vials containing a medicament which eliminates the problems associated with a malleable metal cap or collar such as aluminum.
  • the plastic closure of this invention may be used as a cap to seal a conventional vial having an elastomeric stopper or as a collar for retaining a fluid transferset separate from or integral with the collar.
  • Such substances may be in a dry or powdered form to increase shelf life and reduce inventory space.
  • Such dry or powdered substances are generally stored in a sealed vial and later reconstituted in liquid form for administration to a patient by adding a diluent or solvent.
  • the substance may be in liquid or even gaseous form.
  • a conventional vial for storing a pharmaceutical substance generally includes an open end, a radial rim portion surrounding the open end and a reduced diameter neck portion adjacent the rim portion.
  • the vial is conventionally sealed with an elastomeric stopper which generally includes a tubular portion inserted into the neck of the vial and a planar rim portion which overlies the vial rim.
  • the stopper is normally secured to the vial with a thin malleable metal cap, such as aluminum.
  • the aluminum cap includes a tubular portion which surrounds the rim portions of the stopper and vial, an inwardly projecting annular portion which overlies the rim portion of the stopper and a distal end portion which is crimped or deformed radially into the vial neck beneath the vial rim portion. Because aluminum is malleable, the collar accommodates the buildup of tolerances of the dimensions of the stopper and vial rim.
  • the dimensions and tolerances of standard vials and stoppers are set by the International Standards Organization (ISO).
  • the radial portion of the aluminum cap which overlies the stopper rim portion may be closed, in which case the aluminum cap is removed by "peeling" the aluminum cap from the vial.
  • a pre-slit tab located in the middle area is provided which overlies the vial rim, permitting the cap to be torn from the top and peeled from the vial prior to use.
  • This closed embodiment of an aluminum cap has several disadvantages. First, the tearing of the metal cap creates sharp edges which may cut or damage sterile gloves and cut the person administering the drug, thereby exposing both the healthcare worker and the patient to disease and contamination of the drug. Second, the tearing of the aluminum cap generates metal particles which may also contaminate the drug.
  • the aluminum collar includes a central opening and a shallow plastic cup-shaped cap is received over the aluminum collar having a central projecting riveting portion which is received and secured in the central opening of the aluminum collar.
  • the plastic cap is then removed by forcing the flip-off cap away from the aluminum collar, which tears an annular serrated portion surrounding the central opening and exposes an opening in the collar for receipt of a hypodermic needle or the like.
  • This embodiment reduces but does not eliminate the possibility of tearing the sterile gloves of the healthcare worker. More importantly, however, aluminum dust is still created which may contaminate the medicament.
  • Aluminum collars have also been used to secure a fluid transferset on vials. Transfersets may be utilized, for example, to transfer fluid from a syringe to a vial, such as to reconstitute a dry or powdered substance in a vial by adding a diluent or solvent. The reconstituted substance may then be withdrawn from the vial by the syringe.
  • the inner surface of the transferset may be part of the fluid path and the aluminum collar or ring may bring aluminum particles in the sterile room where the substance is added to the vial or into the fluid path contaminating the substance.
  • the prior art also includes snap-on cup-shaped plastic caps or collars having a radially inwardly projecting end portion which is snapped over the rim portion of the vial. Snap-on plastic collars, however, do not assure adequate sealing of the vial or fully accommodate the tolerances of standard vials and stoppers as required.
  • a plastic closure for sealing a container corresponding to the first part of claim 1 is disclosed in FR-A-1328635.
  • the plastic closure comprises an end wall and a skirt depending therefrom. When the closure has been positioned on the neck of a container, the skirt is deformed by L-shaped tongues, so that the closure is anchored on the container.
  • the plastic closure of this invention solving these problems and permitting the use of the plastic closure of this invention for attaching and sealing containers is defined by claim 1.
  • the polymer has an elongation at yield between 5% and 10%, an elongation at break greater than 100% and a flexural modulus of greater than 1,900MPa.
  • the plastic closure for sealing a cartridge or other medical container of this invention eliminates the problems associated with a malleable metal or aluminum cap or collar, but accommodates the buildup of tolerances of the rim portion of the container and the elastomeric stopper, when used.
  • the plastic closure of this invention is relatively inexpensive to manufacture and use.
  • the plastic closure of this invention may be utilized as a cap to seal a conventional pharmaceutical cartridge.
  • the term closure is generic to either a cap or collar.
  • the plastic closure for sealing a container of this invention may be utilized with any number of conventional cartridges having an open end and a reduced diameter neck portion adjacent the open end.
  • the plastic closure of this invention includes a generally tubular portion and a portion which is deformed radially or crimped toward the reduced diameter portion of the container to retain the closure on the container and as a cap to seal the open end of the container.
  • the plastic closure of this invention may also be used as a cap or collar with a conventional vial and elastomeric stopper.
  • the plastic closure of this invention is formed of a polymer which is sufficiently malleable to permit radial deformation, yet sufficiently rigid to retain its shape following deformation and sufficiently resistant to creep to maintain the seal between the plastic cap and the container following radial deformation.
  • the preferred embodiment of the plastic closure of this invention is formed of a composite polymer including a polymer alloy or melt blend which includes a relatively tough soft malleable co-polymer and a relatively rigid polymer.
  • the composite polymer is a polymer alloy of a relatively soft malleable co-polymer and a relatively rigid polymer.
  • the preferred relatively rigid polymer is a polyamide or a polycarbonate and the preferred relatively soft co-polymer may be selected from polyesters or polyolefins.
  • the resultant polymer alloy or composite preferably has an elongation at yield between 5% and 10% and an elongation at break greater than 100% with a flectural modulus of greater than 1900 MPa.
  • the plastic closure of this invention includes a generally cylindrical tubular portion preferably having an internal diameter generally equal to or slightly greater than the external diameter of the rim portion of the container adapted to be received over the rim portion of the container having a free distal end adapted to be deformed radially inwardly or crimped beneath the rim portion of the container and sealed relation.
  • the plastic cap or collar of this invention may also include a radially inwardly projecting proximate portion which overlies the rim portion of the container and/or the stopper.
  • This radial portion may be closed or more preferably includes a central opening which may be closed with a flip-off or peel-off type plastic closure or seal.
  • the peel-off seal includes a looped end portion which is welded or glued in place to provide an indication of tampering and a free end which may be gripped to remove the seal.
  • the method of this invention includes forming a plastic closure having a generally cylindrical tubular portion having an internal diameter generally equal to or slightly greater than an outside diameter of the rim portion of the container and an integral radial rim portion, disposing the closure over the rim of the container with the radial rim portion overlying the rim portion of the vial and the tubular portion surrounding the container rim, and then radially permanently deforming or crimping the free end of the tubular portion of the collar toward the neck portion of the container, beneath the rim portion, permanently securing the closure on the container and sealing the container open end.
  • the plastic closure of this invention is formed by injection molding the plastic closure from a polymeric alloy or a composite having a relatively soft malleable polymer or co-polymer and a relatively rigid polymer, wherein a polymeric alloy or composite is formed during the injection molding.
  • a resilient or polymeric ring is utilized to prevent rotation of the closure on the container, the ring may be co-injected with the polymer forming the closure or an annular groove may be formed in the tubular portion of the closure, adjacent the free end.
  • the method then includes inserting the annular resilient ring in the groove prior to radial permanent deformation of the free end of the closure as described, such that the resilient ring is biased against the rim portion of the container.
  • a thermoplastic elastomer may also be co-injected with the polymer forming the closure to form a coating or film on the inside surface of the closure which is integrally bonded to the polymer of the cap.
  • the plastic closure of this invention may be utilized with a cartridge or other medical container having a conventional elastomeric stopper or as a collar in combination with a transferset having a sealing member as disclosed in the prior art or more preferably the collar portion may be formed integral with components of the transferset.
  • the plastic closure of this invention is used to seal a container having an elastomeric stopper, the proximate radial lip of the closure is received over and preferably biased against the resilient radial lip of the stopper during radial deformation or crimping of the free of the tubular portion of the closure beneath the rim of the container.
  • the plastic closure of this invention thus eliminates the problems associated with malleable metal collars or caps, such as aluminum, and is relatively inexpensive, and simple to manufacture, particularly when compared with aluminum caps having a protective coating.
  • the plastic closure of this invention assures an excellent seal of the container and can be injection molded in a clean environment or washed, if necessary.
  • the plastic closure of this invention accommodates the tolerances of the vial and particularly the buildup of tolerance variations in the combination of a conventional vial and elastomeric stopper.
  • FIGs 1 to 3 illustrate one preferred embodiment of a pharmaceutical substance container, stopper and cap assembly 20 of this invention.
  • the closure of this invention may be utilized to seal various containers and is particularly useful for sealing containers for holding pharmaceuticals such as the conventional vial 22 illustrated in Figures 1 to 3 and the cartridges shown in Figures 4 through 8.
  • the vial includes an open end 24, an annular radially extending rim portion 26 and a neck portion 28 adjacent the rim portion.
  • the neck portion 28 of the vial has a reduced diameter when compared to the rim portion 26 and the container portion 30.
  • the internal surface 31 of the vial adjacent the open end 24 is generally cylindrical.
  • Medicament vials of this type are generally formed of glass or a sterilizable plastic.
  • the open end 24 of the vial is typically closed with an elastomeric stopper 32 having a tubular body portion 34 which is received in the open end 24 of the vial and a planar rim portion 36 which overlies the rim portion 26 of the vial as shown in Figure 1.
  • the stopper is generally formed of a resilient elastomeric material such as synthetic or natural rubber.
  • the central portion 38 of the planar rim portion 36 may be pierced with a hypodermic needle, for example, to either withdraw fluid from the vial or add a solvent or diluent to the vial where the substance in the vial is in dry or powder form.
  • the tubular portion 34 of the stopper has an external diameter generally greater than the internal diameter of the internal cylindrical surface 31 of the vial to provide a tight or interference fit.
  • FIG. 1 One preferred embodiment of the closure 40 is shown in Figure 1 attached to a vial 22 and stopper 32 assembly, prior to assembly in Figure 2 and during assembly in Figure 3.
  • This embodiment of the collar 40 includes a tubular portion 42 which surrounds the rim portion 26 of the vial and the planar rim portion 36 of the stopper. Where the external surface of the rim portion 26 of the vial is cylindrical, the tubular portion 42 of the collar will generally also be cylindrical. As shown in Figure 1, the free end 44 of the tubular portion 42 is deformed inwardly or crimped beneath the adjacent surface of the rim portion 26 of the vial, permanently securing the collar 40 on the vial and sealing the vial.
  • This embodiment of the collar 40 also includes an integral radial proximate portion 46 which overlies the rim portions 26 and 36 of the vial and stopper, respectively.
  • the radial portion 46 is preferably integral with the tubular portion 42 of the collar.
  • This embodiment of the collar 40 also includes a central opening 48 which overlies the central portion 38 of the stopper, preferably coaxially aligned with the central portion of the stopper. As described below, however, the central opening 48 may be eliminated in certain applications of this invention.
  • proximate and distal are used solely for ease of description, wherein the term proximate refers to elements or portions of elements closest to the rim portion 36 of the stopper and distal refers to elements or portions of elements more remote from the rim portion of the stopper. Further, the terms cap and collar are sometimes used herein interchangeably.
  • the illustrated collar 40 includes a shallow cup-shaped cap 50.
  • the cap 50 includes a tubular portion 52 which surrounds the proximate portion of the tubular portion 42 of the collar, an integral central radial bridging portion 54 and a plurality of U-shaped tabs which, in the disclosed embodiment, are integral with the central bridging portion 54.
  • the U-shaped tabs 56 are received through the central opening 48 of the collar and snap in place to securely retain the cap 50 on the collar 40.
  • the cap 50 may be preassembled on the collar 40 prior to assembly of the collar on the vial.
  • the tabs 56 may also be separate members or the central portion of the cap 50 including the tabs 56 may be a separate member.
  • the collar 40 is then assembled on the vial 22 as shown in Figure 2.
  • the tubular portion 34 of the stopper is first inserted into the opening 24 of the vial 22 generally after the vial is filled.
  • the plastic collar 40 of this invention may be used with various containers including conventional medicament vials as shown.
  • the vial 22 will first be filled with a medicament.
  • the tubular portion 42 of the collar 40 is then received over the rim portion 36 of the stopper and the rim portion 26 of the vial as shown in Figure 3.
  • the free end 44 (shown before deformation in phantom in Figure 3) is then deformed radially beneath the radial rim 26 of the vial by a suitable tool, such as the crimping tool 58 shown in Figure 3.
  • the disclosed embodiment of the crimping tool includes a conical rim 60 which deforms or crimps the free end 44 of the collar beneath the rim 26 of the vial.
  • the tool 58 is rotated around the rim 26 of the collar 40, deforming or crimping the free end 44 as shown in Figures 1 and 3.
  • the sealed vial may now be stored for later use.
  • the cap 50 When the vial is ready for use, the cap 50 may be removed simply by forcing one side of the cap 50 upwardly away from the collar 40, removing the cap 50 from the collar 40 and exposing the central opening 48 of the collar and the central portion 38 of the stopper. The central portion 38 of the stopper may then be pierced with a conventional hypodermic needle, for example, providing access to the container portion 30 of the vial.
  • a conventional hypodermic needle for example, providing access to the container portion 30 of the vial.
  • the material of the cap 50 is selected to provide resiliency, such as polyethylene or polypropylene
  • the tabs 56 will bend under thumb pressure, permitting easy removal of the closure 50.
  • the material of the cap is relatively rigid, at least some of the tabs 56 will break also permitting removal of the cap.
  • the radial portion 46 of the collar is preferably compressed against the resilient rim portion 32 of the elastomeric stopper during radial deformation of the free end 44 of the collar to assure a secure seal of the vial following installation.
  • the tabs 56 are thus compressed into the radial rim 32 of the stopper as shown in Figure 1.
  • the polymer selected for the plastic closure of this invention can best be described by its required physical properties.
  • the polymer must be sufficiently malleable to permit radial deformation or crimping, yet sufficiently rigid to retain its shape following deformation.
  • the polymer must also be sufficiently resistant to creep to maintain the seal between the plastic cap and the container following radial deformation. It has been found that a polymer having an elongation at yield between 5% and 10% and an elongation at break greater than 100%, combined with a flexural modulus of greater than 1,900 MPa has superior performance.
  • the polymer should also be sterilizable and, in certain applications such as the plastic collar for a vial transferset described below, the polymer is preferably relatively clear and maintains its clarity under the stress of deformation or crimping. It has been found that certain polymer alloys or composite polymers including melt blends or alloys and co-polymers having polymers of different malleability and rigidity are preferred in many applications. That is, the plastic closure of this invention is preferably formed of a polymer alloy, composite polymer or co-polymer including a relatively rigid polymer and a tough relatively soft malleable co-polymer.
  • the most preferred polymer is a polymer alloy or melt blend including a polyamide or polycarbonate as the rigid polymer providing the strength and resistance to creep desired for this application.
  • the relatively soft malleable co-polymer may be selected from various polymers including polyesters and polyolefins; however, a polymer alloy including a polycarbonate or polyamide and a polyester has been found particularly suitable for this application.
  • plastic collar of this invention is not limited to a specific polymer, provided the polymer has the desired physical properties described above.
  • Suitable polymers for the plastic collar of this invention include EASTAR ® MB polymers, which are melt blend and alloy polymers and EASTAR ® thermoplastic polymers, which are neat polymers sold by Eastman Chemical Company of Kingsport, Tennessee and Eastman Chemical AG of Switzerland under the trade names "DA003, DN003" and "DN004". These materials are polymer melt blends, alloys and co-polymers of polycarbonate or polyamide and polyester.
  • melt blends and alloys refer to polymeric compositions having two or more polymers of different physical properties or characteristics, such as the EASTAR ® polymers of Eastman Chemical Company described above which include a polycarbonate or polyamide and a polyester.
  • the polymer selected for the plastic collar of this invention may also include fillers and other constituents which would be more accurately described as a composite.
  • the base polymers may still be a polymeric melt blend or alloy.
  • composite is used in its broadest sense to include alloys or melt blends, composites and co-polymers. As will be understood, the manufacturer or supplier of the raw material will normally blend the polymers based upon the specifications of the customer.
  • the polymers may be co-injected to form a polymeric melt blend, alloy or composite or formed by any other suitable processes. It is anticipated, however, that other polymers having the described physical characteristics may also be utilized in the plastic collar or cap of this invention. In certain applications, it may also be desirable to coat at least the interior surface 43 of the collar shown in Figure 2 with a thermoplastic elastomer, or the entire collar may have a thin layer of a thermoplastic elastomer. The thermoplastic elastomer coating may be applied as a film or by co-injection with the polymer forming the collar 40. The collar 40 and the closure 50 may be formed by conventional injection molding processes.
  • FIGS 1-3 include an illustration of a generic vial or container for a pharmaceutical substance
  • this invention is particularly useful for closing off or sealing cartridges that are prefilled with pharmaceutical substances.
  • Such cartridges are well-known and typically are used with injector devices where the cartridge is inserted into the appropriate portion of the injector device by a medical professional prior to administering an injection.
  • the cartridges typically are prefilled with the desired pharmaceutical substance.
  • a variety of cartridge designs are utilized to accommodate substances in different forms.
  • FIGS 4 and 5 illustrate one example cartridge that includes a plastic closure 140 designed according to this invention.
  • the cartridge 122 is utilized within an injector device that is schematically illustrated at 180.
  • the cartridge 122 includes an open end 124 that is closed off by an elastomeric stopper member 132 in cooperation with the plastic closure 140.
  • a stopper member 170 operates to maintain a substance within the interior 131 of the cartridge 122.
  • the stopper member 170 also cooperates with the injector mechanisms schematically illustrated at 160 of the injector 180 in a conventional manner.
  • the elastomeric stopper member 132 extends across the opening 124 and includes a portion 136 that rests against the rim portion 126 of the cartridge 122.
  • a central portion 138 of the stopper member 132 extends across the opening 124 and is piercable by a hypodermic needle device, for example, so that a pharmaceutical substance within the cartridge 122 can be injected in a desired manner.
  • the cap 140 has a portion 144 that is crimped or radially deformed inwardly toward the reduced neck portion 128 of the cartridge 122.
  • the radial portion 146 of the cap 140 effectively maintains the stopper member 132 in place against the end of the shoulder portion 126 of the cartridge 122.
  • Figures 6 and 7 illustrate another example embodiment where a plastic closure designed according to this invention is provided on the end of a cartridge 222.
  • the cartridge 222 includes two stopper members 270 and 272.
  • a first substance 276 is maintained between the stoppers 270 and 272 when the cartridge 222 is prefilled by a pharmaceutical supplier, for example.
  • a second substance 278 is maintained between the stopper 272 and the stopper member 232 at the open end of the cartridge 222.
  • a bypass passage 274 is provided so that when an injector mechanism is used and a stopper member 270 is moved toward the end of the cartridge 222 including the stopper member 232, the stopper member 272 proceeds in the same direction and the substance or fluid 276 is permitted to flow through the bypass 274 to mix with the substance 278.
  • this type of cartridge is a especially useful for prefilling cartridges with pharmaceutical substances that are maintained in a dry, powdered or lyophilized form.
  • the substance 276 is typically used for reconstituting the substance 278 prior to injecting that substance into a patient.
  • the cap 240 includes the tubular collar portion 242 and the radially crimped or deformed portion 244 that both at least partially engage the shoulder portion 226 at the end of the cartridge 222.
  • the stopper member 232 in this embodiment includes a central portion 238 and an additional flange portion near the end 236 for engaging the end of the cartridge 222. Otherwise, the operation of the example of Figures 6 and 7 is the same as described above.
  • Figure 8 illustrates another embodiment where a plastic cap 340 designed according to this invention is used to close off the end of a cartridge 322.
  • the cartridge 322 includes a stopper member 338 at the open end 324 and a stopper or plunger member 370 at the opposite end.
  • a chamber separating portion 384 operates to maintain substances within the chambers 380 and 382 separate from each other until a desired sequence of injection or a desired mixing operation needs to be completed.
  • the operation of a multi-chamber cartridge such as that illustrated in Figure 8 is known in the art.
  • the inclusion of a plastic cap 340 designed according to this invention provides additional advantages compared to the use of conventional aluminum caps as described above.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Closures For Containers (AREA)

Claims (18)

  1. Fermeture en plastique (40) pour fermer hermétiquement un récipient (22, 122, 222, 322) ayant une extrémité ouverte (24, 124, 324) et une partie à diamètre réduit (28, 128, 228, 328) adjacente à ladite extrémité ouverte, ladite fermeture en plastique comprenant un polymère qui est suffisamment malléable pour permettre la déformation radiale, mais suffisamment rigide pour conserver sa forme suite à la déformation et suffisamment résistant au fluage afin de rester dans une position souhaitée sur ledit récipient suite à la déformation radiale,
    caractérisée en ce que :
    ledit polymère a un allongement à l'élasticité compris entre 5 % et 10 %, un allongement à la rupture supérieur à 100 %, et un module de flexion supérieur à 1 900 MPa.
  2. Fermeture en plastique selon la revendication 1, dans laquelle ledit polymère est relativement transparent et conserve sa transparence sous la contrainte de déformation.
  3. Fermeture en plastique selon la revendication 1 ou 2, dans laquelle ladite fermeture en plastique comprend un copolymère composite comprenant un polymère malléable relativement souple et un polymère relativement rigide.
  4. Fermeture en plastique selon la revendication 3, dans laquelle ladite fermeture en plastique comprend un alliage polymère comprenant un copolymère malléable souple et ledit polymère relativement rigide.
  5. Fermeture en plastique selon la revendication 3 ou 4, dans laquelle ledit polymère relativement rigide est un polycarbonate ou un polyamide.
  6. Fermeture en plastique selon les revendications 3 et 4, dans laquelle ledit polymère relativement souple est un polyester ou un polyoléfine.
  7. Fermeture en plastique selon la revendication 1, dans laquelle ladite fermeture en plastique comprend un revêtement élastomère sur une surface interne d'une extrémité libre de ladite partie tubulaire et ledit revêtement élastomère étant relié de manière solidaire à ladite surface interne.
  8. Combinaison comprenant la fermeture en plastique selon l'une quelconque des revendications 1 à 7 et un récipient, dans laquelle ledit récipient (22, 122, 222, 322) comprend un bord radial (26, 126, 226, 326) adjacent à ladite extrémité ouverte, ladite fermeture en plastique ayant une partie tubulaire (42, 142, 242, 342) entourant ledit bord de récipient et une partie (44, 144, 244, 344) qui est déformée de manière permanente radialement vers ladite partie à diamètre réduit (28, 128, 228, 328) dudit récipient, ladite partie tubulaire de ladite fermeture comprenant une bague élastique annulaire retenue sur une surface interne adjacente à ladite extrémité libre empêchant la rotation de ladite fermeture sur ledit récipient.
  9. Combinaison comprenant la fermeture en plastique selon l'une quelconque des revendications 1 à 7 et un récipient, dans laquelle ledit récipient comprend un bord radial (26, 126, 226, 326) adjacent à ladite extrémité ouverte et une butée élastomère (32, 132, 232, 332) s'étendant sur ladite extrémité ouverte dudit récipient et recouvrant ladite partie de bord dudit récipient, ladite fermeture ayant une partie tubulaire (42, 142, 242, 342) entourant ladite partie de bord dudit récipient ayant une extrémité distale libre déformée radialement vers l'intérieur et mettant en prisé ladite partie de bord dudit récipient et une partie radiale proximale solidaire (46, 146, 246, 346) recouvrant ladite partie de bord de ladite butée.
  10. Combinaison selon la revendication 9, dans laquelle ladite partie radiale proximale (46, 146, 246, 346) de ladite fermeture comprend une ouverture centrale (48) recouvrant une partie centrale (38) de ladite butée et ladite fermeture comprenant un capuchon en forme de coupelle (50) ayant une partie tubulaire (52) recouvrant une partie proximale de ladite fermeture et une partie radiale recouvrant ladite ouverture centrale de ladite fermeture et ledit capuchon étant fixé sur ladite fermeture par des éléments de retenue reçus à l'intérieur de ladite ouverture centrale de ladite fermeture.
  11. Combinaison selon la revendication 10, dans laquelle lesdits éléments de retenue sont des pattes en forme de U espacées solidaires avec ledit capuchon reçu à travers ladite ouverture centrale de ladite fermeture ayant chacune une extrémité libre mettant en prise une partie de ladite fermeture adjacente à ladite ouverture centrale.
  12. Combinaison selon la revendication 11, dans laquelle ledit récipient est une cartouche adaptée pour contenir une substance pharmaceutique.
  13. Combinaison selon la revendication 12, dans laquelle ladite cartouche a au moins deux chambres.
  14. Combinaison selon la revendication 12, dans laquelle ladite cartouche comprend plus d'un élément de butée qui déplacent sélectivement plusieurs substances à l'intérieur de ladite cartouche.
  15. Combinaison selon la revendication 12, dans laquelle la cartouche a une pluralité de chambres.
  16. Combinaison selon la revendication 15, comprenant une pluralité d'éléments de butée qui se déplacent à l'intérieur de la cartouche pour séparer ou mélanger sélectivement différentes substances contenues dans la pluralité de chambres, respectivement.
  17. Combinaison selon la revendication 15, comprenant une dérivation qui permet le mouvement sélectif de la substance à partir de l'une de la pluralité de chambres vers une autre de la pluralité de chambres.
  18. Combinaison selon la revendication 12, comprenant un élément d'étanchéité de butée élastomère.
EP00121655A 1999-10-20 2000-10-04 Fermeture en plastique pour flacons et autres recipients medicaux Expired - Lifetime EP1094012B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US421657 1995-04-13
US42165799A 1999-10-20 1999-10-20

Publications (3)

Publication Number Publication Date
EP1094012A2 EP1094012A2 (fr) 2001-04-25
EP1094012A3 EP1094012A3 (fr) 2002-06-19
EP1094012B1 true EP1094012B1 (fr) 2006-12-13

Family

ID=23671475

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00121655A Expired - Lifetime EP1094012B1 (fr) 1999-10-20 2000-10-04 Fermeture en plastique pour flacons et autres recipients medicaux

Country Status (6)

Country Link
EP (1) EP1094012B1 (fr)
JP (1) JP2001171717A (fr)
AT (1) ATE348052T1 (fr)
AU (1) AU774241B2 (fr)
DE (1) DE60032307T2 (fr)
ES (1) ES2275466T3 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0129176D0 (en) 2001-12-06 2002-01-23 Dca Design Int Ltd Improvements in and realting to a medicament cartridge assembly
JP4526480B2 (ja) * 2003-06-03 2010-08-18 大成化工株式会社 容器のキャップ
DE102012102881A1 (de) * 2012-04-03 2013-10-10 Datwyler Pharma Packaging International Nv Verfahren zur Herstellung einer Bördelkappe, Bördelkappe und Behältnis mit Bördelkappe
EP2826458A1 (fr) 2013-07-17 2015-01-21 F.Hoffmann-La Roche Ag Capuchon pour ampoule
AT519670B1 (de) * 2017-06-27 2018-09-15 Greiner Packaging Int Gmbh Verschlussanordnung für einen Verpackungsbehälter sowie daraus gebildete Verpackungseinheit
JP7160951B2 (ja) * 2019-01-25 2022-10-25 株式会社ダイセル 耐亀裂性部材
FR3106339B1 (fr) * 2020-01-16 2021-12-24 A Raymond Et Cie Coiffe de verrouillage pour recipient a col avec une capsule a pattes de fixation secables

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB999159A (en) * 1961-07-05 1965-07-21 Taylor Pty Ltd Samuel Improvements in or relating to caps for containers, bottles or the like
US3278063A (en) * 1963-02-02 1966-10-11 Faensen Kleinmetall Sealing device
US3857579A (en) * 1973-04-06 1974-12-31 J Hoodenpyle Cart for moving television, hi-fi cabinets and the like
JPS5826914Y2 (ja) * 1979-04-20 1983-06-10 旭硝子株式会社 アンプル瓶
US5662230A (en) * 1990-07-13 1997-09-02 J. G. Finneran Associates Crimp top seal for vials
SE9201246D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Injection cartridge arrangement
JP3633666B2 (ja) * 1995-05-12 2005-03-30 大成化工株式会社 樹脂製上蓋、それが緊締キャップ頂面に適度に接合された樹脂製の密封兼緊締ユニット及び密封兼緊締ユニットの製造方法
AU720748B2 (en) * 1996-04-22 2000-06-08 Abbott Laboratories Container closure system
JPH09327500A (ja) * 1996-06-07 1997-12-22 Material Eng Tech Lab Inc 薬剤容器及びそれを具備した輸液容器
US5718348A (en) * 1996-09-12 1998-02-17 Comar, Inc. Overcap assembly for gear finish vial

Also Published As

Publication number Publication date
AU774241B2 (en) 2004-06-24
EP1094012A2 (fr) 2001-04-25
DE60032307T2 (de) 2007-06-28
EP1094012A3 (fr) 2002-06-19
ES2275466T3 (es) 2007-06-16
DE60032307D1 (de) 2007-01-25
JP2001171717A (ja) 2001-06-26
AU6655500A (en) 2001-05-10
ATE348052T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
US6382442B1 (en) Plastic closure for vials and other medical containers
EP1221923B1 (fr) Materiel de transfert pour flacons et autres recipients medicaux
AU782339B2 (en) Transfer set for vials and medical containers
US6681475B2 (en) Method of sealing a medical container with a plastic closure
US6904662B2 (en) Method of sealing a cartridge or other medical container with a plastic closure
EP1094012B1 (fr) Fermeture en plastique pour flacons et autres recipients medicaux

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

RIC1 Information provided on ipc code assigned before grant

Free format text: 7B 65D 51/00 A, 7B 65D 41/10 B, 7A 61J 1/00 B

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20021113

AKX Designation fees paid

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: PLASTIC CLOSURE FOR VIALS AND OTHER MEDICAL CONTAINERS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BECTON DICKINSON AND COMPANY

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061213

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061213

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061213

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061213

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60032307

Country of ref document: DE

Date of ref document: 20070125

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070313

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ISLER & PEDRAZZINI AG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070514

ET Fr: translation filed
NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2275466

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: ISLER & PEDRAZZINI AG;POSTFACH 1772;8027 ZUERICH (CH)

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20070914

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070314

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071004

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071004

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061213

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20190919

Year of fee payment: 20

Ref country code: IT

Payment date: 20190918

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20190923

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20190923

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20190918

Year of fee payment: 20

Ref country code: CH

Payment date: 20190923

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20191104

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60032307

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20201003

Ref country code: BE

Ref legal event code: MK

Effective date: 20201004

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20210128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20201003

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20201005